If GTC is increasing the herd, this would lend creedence to the fact that the results have not gone horribly wrong. I must say I am curious to the results of Merrimack's results. I would expect to hear results by at least the 1st of the year, since you say this is their cash raising season.
Some other things I have wondered is: Why if they already have alpha-1-antitrypsin being produced in sufficient quantities, then why would it take several years to even develop a phase I study?
Relatively speaking, is albumin at a price level that is somewhat affordable that GTC does not find this as profitable venture to pursue?
News 
Market Data 
Discover 
